Phase 2
๐ Investigational Drug / Biologic
NCT05613413
A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
๐ Ryan Nguyen โ Chicago, Illinois
View Study & Screener โ